Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
Clinical trial NCT01521663 · COMPLETED
Trial details
- NCT number
- NCT01521663
- Sponsor
- Impax Laboratories, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2013-02-01
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.